| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |